This new funding opportunity is part of the Government of Canada's continued rapid response to address the health challenges of the COVID-19 pandemic. The funding will enable rapid and timely research responsive to the current phase of COVID-19 pandemic in Canada and around the globe.
Funding will support clinical trials, observational studies, implementation science or other relevant study designs to scale-up promising existing projects, reorient current research, or initiate new rapid response research to address COVID-19 in the identified research areas that include understanding the safety, efficacy, effectiveness, ethics, and implementation of:
vaccines, diagnostics, or therapeutics;
clinical management and health system interventions; and
social, policy, and public health responses and related indirect consequences.
Application Deadline: May 11, 2020
Anticipated Notice of Decision: June 2, 2020
Funding Start Date: May 1, 2020
Approximately $107.9M of funding is available.
The maximum amount per grant that can be requested for clinical trial research is $5,000,000 over 1 year.
The maximum amount per grant that can be requested for all other types of research is $2,500,000 over 1 year.
Peer Reviewer Recruitment
Given the urgency of this funding competition, recruitment for peer reviewers will begin immediately. If you are interested and available to volunteer as a peer reviewer, please reach out to CIHR immediately at EHTRF-FRNMS@cihr-irsc.gc.ca. We thank applicants and peer reviewers in advance for their flexibility and understanding with respect to the need for this expedited process.
CIHR is providing a linkage tool that is intended to facilitate connections and collaborations (domestically and internationally) should there be interest.
For all inquiries, please contact EHTRF-FRNMS@cihr-irsc.gc.ca